Vineet Laboratories Ltd (VINEETLAB) Share Price & Fundamentals

What we do

Vineet Laboratories Limited manufactures intermediates essential for active pharmaceutical ingredients, serving both domestic and export markets with specialized chemical synthesis capabilities.

Founded in

2,016

Market share

Not a market leader but supplies to significant pharmaceutical companies domestically and internationally with niche capabilities in pyrophoric chemicals.

Problem solved

Provides high-quality API intermediates and custom synthesis to pharmaceutical firms, enabling efficient drug production and innovation.

Top clients or who we serve

B2B serving pharmaceutical manufacturers including Gilead Sciences (USA), Teva, Mylan, Cipla, and others.

Key management

-

Our journey and innovations

Incorporated in 2016, demerged API intermediates division in 2020; specializes in low-temperature and pyrophoric chemical manufacturing.

Where we operate

Primarily India with export focus to various international markets.

Top products or what we offer

API intermediates, bulk drugs, fine chemicals, custom synthesis products including n-Butyl Lithium handling.

Top brands

-

Raw materials needed

Various chemical raw materials and solvents for API intermediate production.

Raw materials supplier

-

Recurring vs cyclical contribution

Revenue is cyclical, linked to pharmaceutical manufacturing demand.

Our industry position

Positioned as a niche supplier of specialized drug intermediates with growing export presence.

Financial highlights

FY 2024-25 revenue Rs. 75 Cr; net loss Rs. 20.19 Cr; revenue declined from Rs. 150 Cr previous year due to market conditions.

Geographical revenue split

Nearly 75% revenue from Indian operations; rest from exports.

Order book

-

Whats driving growth

Demand for specialized intermediates, export collaborations, and manufacturing innovations.

Our future plans

Focus on capacity enhancement, custom synthesis expansion, and enhancing export partnerships.

Our green promise

-

Our people and values

Committed workforce with focus on safety and compliance; fostering ethical and transparent culture.

Key challenges ahead

Working capital constraints and market fluctuations impacting profitability.

Interesting facts

Equipped to handle pyrophoric chemicals and operations at temperatures as low as -100°C.

Risks and strategy

Mitigating operational risks via strong internal controls and diversified client base.